Citations (9)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Fabiana Fiasca, Stefano Necozione & Antonella Mattei. (2021) Pertussis in Italy: how to protect the “unprotectable”?. Human Vaccines & Immunotherapeutics 17:4, pages 1136-1141.
Read now
Read now
Shabir A. Madhi & Marta C. Nunes. (2018) Experience and challenges on influenza and pertussis vaccination in pregnant women. Human Vaccines & Immunotherapeutics 14:9, pages 2183-2188.
Read now
Read now
Articles from other publishers (7)
Librada Fortuna, Surasith Chaithongwongwatthana, Ngamphol Soonthornworasiri, Jane Spiegel, Wassana Wijagkanalan, Souad Mansouri, Anita H.J. van den Biggelaar & Hong Thai Pham. (2020) Enhanced post-licensure safety surveillance of a new recombinant acellular pertussis vaccine licensed as a monovalent (aP, Pertagen®) and tetanus, reduced-dose diphtheria combination (TdaP, Boostagen®) vaccine for immunization of adolescents and adults in Thailand. Vaccine 38:51, pages 8194-8199.
Crossref
Crossref
Natasha S. Crowcroft, Kevin L. Schwartz, Cynthia Chen, Caitlin Johnson, Ye Li, Alex Marchand-Austin, Shelly Bolotin, Frances B. Jamieson, Steven J. Drews, Margaret L. Russell, Lawrence W. Svenson, Kimberley Simmonds, Salaheddin M Mahmud & Jeffrey C. Kwong. (2019) Pertussis vaccine effectiveness in a frequency matched population-based case-control Canadian Immunization Research Network study in Ontario, Canada 2009–2015. Vaccine 37:19, pages 2617-2623.
Crossref
Crossref
Edith Acquaye-Seedah, Elizabeth E. Reczek, Hugh H. Russell, Andrea M. DiVenere, Sara O. Sandman, Joseph H. Collins, Caitlin A. Stein, Timothy A. Whitehead & Jennifer A. Maynard. (2018) Characterization of Individual Human Antibodies That Bind Pertussis Toxin Stimulated by Acellular Immunization. Infection and Immunity 86:6.
Crossref
Crossref
Shruti Murthy, Myron Anthony Godinho, Theophilus Lakiang, Melissa Glenda G Lewis, Leslie Lewis & N. Sreekumaran Nair. (2018) Efficacy and safety of pertussis vaccination in pregnancy to prevent whooping cough in early infancy. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Sirintip Sricharoenchai, Chukiat Sirivichayakul, Kulkanya Chokephaibulkit, Punnee Pitisuttithum, Jittima Dhitavat, Arom Pitisuthitham, Wanatpreeya Phongsamart, Kobporn Boonnak, Keswadee Lapphra, Yupa Sabmee, Orasri Wittawatmongkol, Pailinrut Chinwangso, Indrajeet Kumar Poredi, Jean Petre, Pham Hong Thai & Simonetta Viviani. (2018) A genetically inactivated two-component acellular pertussis vaccine, alone or combined with tetanus and reduced-dose diphtheria vaccines, in adolescents: a phase 2/3, randomised controlled non-inferiority trial. The Lancet Infectious Diseases 18:1, pages 58-67.
Crossref
Crossref
Giorgio Fedele, Maria Carollo, Raffaella Palazzo, Paola Stefanelli, Elisabetta Pandolfi, Francesco Gesualdo, Alberto Eugenio Tozzi, Rita Carsetti, Alberto Villani, Ambra Nicolai, Fabio Midulla & Clara Maria Ausiello. (2016) Parents as source of pertussis transmission in hospitalized young infants. Infection 45:2, pages 171-178.
Crossref
Crossref
Pere Godoy, Manuel García-Cenoz, Diana Toledo, Glòria Carmona, Joan A Caylà, Miquel Alsedà, Josep Àlvarez, Irene Barrabeig, Neus Camps, Pere Plans, María Company, Jesús Castilla, Maria-Rosa Sala-Farré, Carmen Muñoz-Almagro, Cristina Rius & Àngela Domínguez. (2016) Factors influencing the spread of pertussis in households: a prospective study, Catalonia and Navarre, Spain, 2012 to 2013. Eurosurveillance 21:45.
Crossref
Crossref